JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Tenalisib R Enantiomer is the R enantiomer of Tenalisib (also known as RP6530). Tenalisib is a new, potent and selective dual PI3Kdelta/gamma inhibitor with IC50 of 24.5 nM and 33.2 nM for PI3Kdelta and PI3Kgamma, respectively. It displays selective for PI3Kdelta/gamma with selectivity over alpha and beta isoforms of more than 300-fold and 100-fold, respectively. Tenalisib exhibits modest proliferation inhibition (33-46% inhibition at 10 uM) in both HEL-RS and HEL-RR cells. Addition of 10 uM tenalisib to ruxolitinib is synergistic resulting in a near-complete inhibition of proliferation (> 90% for HEL-RS and > 70% for HEL-RR). Addition of 5 uM tenalisib, 4 h prior to the addition of ruxolitinib results in a significant reduction in EC50of ruxolitinib (5.8 uM) in HEL-RR cells.
References: Blood 2015 126:1495
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Recommend by mail
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!